Search

GRIFOLS, S.A.

Page 6 out of 34

from 01/07/1988 to 28/02/2020

The price-sensitive information presented in other languages is a literal translation of the price-sensitive information stated in Spanish

    • 26/01/2018
    • 08:27
    • GRIFOLS, S.A.
    • Others on corporate transactions
    • Acquisition of 51% of the share capital in Goetech LLC (MedKeeper).
    • Register number: 260997
    • Price sensitive information of GRIFOLS, S.A.
    • 05/12/2017
    • 11:49
    • GRIFOLS, S.A.
    • Loans, credit lines and guarantees
    • Grifols has obtained a new long-term loan with the European Investment Bank
    • Register number: 259188
    • Price sensitive information of GRIFOLS, S.A.
    • 22/11/2017
    • 17:42
    • GRIFOLS, S.A.
    • Others on business performance and financial information
    • Grifols inaugurates a plant in Brazil
    • Register number: 258783
    • Price sensitive information of GRIFOLS, S.A.
    • 17/11/2017
    • 17:31
    • GRIFOLS, S.A.
    • R&D: new licenses, patents and registered trademarks
    • Grifols has earned approvals from the U.S. Food and Drug Administration and from the European Medicines Agency
    • Register number: 258667
    • Price sensitive information of GRIFOLS, S.A.
    • 16/11/2017
    • 08:25
    • GRIFOLS, S.A.
    • Information on dividends
    • Details of the interim dividend on account of 2017 profit
    • Register number: 258581
    • Price sensitive information of GRIFOLS, S.A.
    • Price sensitive information of GRIFOLS, S.A.
    • 02/11/2017
    • 08:24
    • GRIFOLS, S.A.
    • Information on P&L
    • Performance summary for the third quarter 2017
    • Register number: 258082
    • Price sensitive information of GRIFOLS, S.A.
    • 02/11/2017
    • 08:22
    • GRIFOLS, S.A.
    • Interim financial information
    • La sociedad remite información sobre los resultados del tercer trimestre de 2017
    • Register number: 258081
    • Intermediate financial information on GRIFOLS, S.A.
    • 30/10/2017
    • 08:18
    • GRIFOLS, S.A.
    • Information on dividends
    • Approval of interim dividend on account of 2017 profit
    • Register number: 257978
    • Price sensitive information of GRIFOLS, S.A.
    • 22/09/2017
    • 08:26
    • GRIFOLS, S.A.
    • R&D: new licenses, patents and registered trademarks
    • Grifols has earned approval from the U.S. Food and Drug Administration for a liquid formulation of its alpha-1 antitrypsin as a replacement therapy to treat alpha-1 antitrypsin deficiency, a rare genetic disorder.
    • Register number: 256616
    • Price sensitive information of GRIFOLS, S.A.
Page 6 out of 34